Johnson & Johnson Form 4 insider transactions

Johnson & Johnson Director Daniel E. Pinto acquired 175.493 Deferred Share Units as part of a compensation plan.

Johnson & Johnson Director Eugene A. Woods acquired 210.591 Deferred Share Units as part of a cash retainer deferral plan.

Jennifer Taubert, EVP at Johnson & Johnson, exercised stock options and subsequently sold the acquired shares for a significant gain.

Johnson & Johnson's Executive VP, General Counsel, Elizabeth Forminard, exercised stock options and subsequently sold a portion of the acquired shares.

Johnson & Johnson CEO Joaquin Duato exercised 125,824 stock options and subsequently sold the acquired shares for a gain, as part of a pre-planned trading arrangement.

Johnson & Johnson's Executive VP and CFO, Joseph J. Wolk, exercised stock options and subsequently sold the acquired shares for personal financial planning.

John C. Reed, EVP of Innovative Medicine, R&D at Johnson & Johnson, sold 19,137 shares of common stock for approximately $163.55 per share under a Rule 10b5-1 plan.

Johnson & Johnson Director Marillyn A. Hewson has acquired 322.103 Deferred Share Units (DSUs) as part of her compensation, reflecting a routine deferral of cash retainer.

Johnson & Johnson Director Eugene A. Woods acquired 231.318 Deferred Share Units (DSUs) on June 10, 2025, as part of the company's director compensation plan.

EVP John C. Reed reports the vesting of restricted share units and subsequent tax withholding.

Eugene A. Woods, a director at Johnson & Johnson, acquired deferred share units (DSUs) as part of the company's Amended and Restated Deferred Fee Plan for Directors.

Director Nadja West acquired 1,316 Deferred Share Units (DSUs) of Johnson & Johnson on April 24, 2025, under the company's Amended and Restated Deferred Fee Plan for Directors.

Mark A. Weinberger, a director at Johnson & Johnson, acquired 1,316 deferred share units under the company's Amended and Restated Deferred Fee Plan for Directors on April 24, 2025.

Director Mark B. McClellan acquired 1,316 deferred share units (DSUs) of Johnson & Johnson on April 24, 2025, under the company's Amended and Restated Deferred Fee Plan for Directors.

Director Hubert Joly acquired 1,316 Deferred Share Units (DSUs) of Johnson & Johnson on April 24, 2025, under the company's Amended and Restated Deferred Fee Plan for Directors.

Paula A. Johnson, a director at Johnson & Johnson, acquired 1,316 deferred share units (DSUs) on April 24, 2025, under the company's Amended and Restated Deferred Fee Plan for Directors.

Director Marillyn A. Hewson acquired deferred share units (DSUs) representing the deferral of cash retainer under Johnson & Johnson's Amended and Restated Deferred Fee Plan for Directors.

Mary C. Beckerle, a director at Johnson & Johnson, acquired 1,316 deferred share units under the company's Amended and Restated Deferred Fee Plan for Directors.

Director Jennifer A. Doudna reports the acquisition of 1,316 Deferred Share Units (DSUs) in Johnson & Johnson on April 24, 2025, under the company's Amended and Restated Deferred Fee Plan for Directors.

CEO Joaquin Duato reports gifting 130,852 shares of Johnson & Johnson common stock to his spouse on March 18, 2025.

Director Marillyn A. Hewson acquired deferred share units (DSUs) of Johnson & Johnson, representing a deferral of cash retainer under the company's Amended and Restated Deferred Fee Plan for Directors.

Director Eugene A. Woods acquired deferred share units (DSUs) representing the fair market value of Johnson & Johnson common stock as part of the company's Amended and Restated Deferred Fee Plan for Directors.

Robert J. Decker, VP Corporate Controller at Johnson & Johnson, reports the exercise of stock options and subsequent sale of shares on February 25, 2025.

Executive VP and CFO of Johnson & Johnson, Joseph J. Wolk, reports the acquisition of stock options and restricted share units under the company's Long-Term Incentive Plan.

Kathryn E. Wengel, EVP, Chief TO and Risk Officer of Johnson & Johnson, reports the acquisition of stock options and restricted share units under the company's Long-Term Incentive Plan.

EVP Jennifer Taubert reports the acquisition of stock options and restricted share units in Johnson & Johnson under the company's Long-Term Incentive Plan.

EVP and CIO of Johnson & Johnson, James D. Swanson, reports the acquisition of stock options and restricted share units under the company's Long-Term Incentive Plan.

EVP Timothy Schmid reports the acquisition of stock options and restricted share units in Johnson & Johnson under the company's Long-Term Incentive Plan.

EVP John C. Reed reports acquisition of stock options and restricted share units in Johnson & Johnson under the company's Long-Term Incentive Plan.

EVP, Chief HR Officer of Johnson & Johnson, Kristen Mulholland, reports the acquisition of stock options and restricted share units under the company's Long-Term Incentive Plan.